The effectiveness of an emotion-focused educational programme in reducing diabetes distress in adults with Type 2 diabetes mellitus (VEMOFIT): a cluster randomized controlled trial
The effectiveness of an emotion-focused educational programme in reducing diabetes distress in adults with Type 2 diabetes mellitus (VEMOFIT): a cluster randomized controlled trial
复制标题
DOI：
10.1111/dme.13615
复制
发表时间：
2018-06-01
影响因子：
3.5
通讯作者：
Rutten, G. E. H. M.
中科院分区：
文献类型：
--
作者：
Chew, B. H.;Vos, R. C.;Rutten, G. E. H. M.
目的：评估一个简短的，以价值为基础的情绪为重点的教育计划（VEMOFIT）在马来成人2型糖尿病患者与积极倾听参与者的情绪体验的计划相比的有效性，社会支持及其对健康门诊糖尿病护理服务的意见方法马来成年人严重糖尿病困扰[糖尿病困扰量表（DDS-17）平均评分3]。VEMOFIT包括四个双周一次的小组会议，3个月后的加强会议和干预后6个月的随访。注意力控制计划在同一时期包括三个阶段。结果包括糖尿病困扰，抑郁症状，自我效能和疾病控制。所需的总样本量为165。结果参与者（n = 124）被随机分配到VEMOFIT（n = 53）或注意力控制程序（n = 71）。参与者的平均（sd）年龄为55.7（9.7）岁，中位糖尿病病程为7.0（8.0）年，平均HbA（1c）水平为82 mmol/mol（9.7%）。VEMOFIT和注意力控制方案的平均DDS-17水平均显著下降（分别为3.4至2.9 vs. 3.1至2.7）。调整后的组间DDS-17差异不显著[-0.01，95%置信区间（CI）-0.38，0.35]。两组中重度糖尿病患者的比例分别从89%降至47%和69%降至39%（比值比0.88; 95% CI 0.26，2.90）。其他结果并没有不同groups.ConclusionsBoth干预减少糖尿病痛苦显着。以理论为基础的VEMOFIT程序并不上级注意力控制程序。后一种方法是减少严重糖尿病痛苦的更简单方法（试验注册：NCT 02730078; NMRR-15-1144-24803）。
AimsTo evaluate the effectiveness of a brief, value-based emotion-focused educational programme (VEMOFIT) in Malay adults with Type 2 diabetes mellitus compared with a programme of active listening to participants' emotional experiences, social support and their opinion on the health clinic diabetes care services (attention control).MethodsMalay adults with severe diabetes distress [Diabetes Distress Scale (DDS-17) mean score 3] were included. VEMOFIT consisted of four biweekly group sessions, a booster session after 3 months and a follow-up 6 months post intervention. The attention control programme consisted of three sessions over the same period. Outcomes included diabetes distress, depressive symptoms, self-efficacy and disease control. Required total sample size was 165.ResultsParticipants (n = 124) were randomized to either VEMOFIT (n = 53) or the attention control programme (n = 71). Participants had a mean (sd) age of 55.7 (9.7) years, median diabetes duration of 7.0 (8.0) years and mean HbA(1c) level of 82 mmol/mol (9.7%). The mean DDS-17 level decreased significantly in both the VEMOFIT and the attention control programmes (3.4 to 2.9 vs. 3.1 to 2.7, respectively). The adjusted between-group DDS-17 difference was not significant [-0.01, 95% confidence interval (CI) -0.38, 0.35]. The proportion of individuals with severe diabetes distress decreased in both groups, from 89% to 47% vs. 69% to 39% (odds ratio 0.88; 95% CI 0.26, 2.90). Other outcomes did not differ between groups.ConclusionsBoth interventions decreased diabetes distress significantly. The theory-based VEMOFIT programme was not superior to the attention control programme. The latter approach is a simpler way to decrease severe diabetes distress (Trial registration: NCT02730078; NMRR-15-1144-24803).